tirzepatide alternatives weight loss diabetes FDA Grants a New Indication for Obesity Management The ABC's of GLP-1s: Benefits,

Absolute vs Relative Risk in Context When discussing the reported pancreatic cancer risk associated with GLP-1 medications, it is essential to distinguish between absolute and relative risk

Market forces are at play in consumer desires

No controlled trials exist in pregnant women for ethical reasons, so the FDA's cautious approach is based on animal data plus the principle that avoidable medication exposure during pregnancy should be minimized

By diversifying products, adjusting marketing, educating consumers, and collaborating with wellness brands, breweries can align with health-conscious trends and build loyalty in the era of GLP-1 drugs